Lanzafame M - Search Results

1

[Klebsiella pneumoniae resistente ai carbapenemici: prevalenza delle infezione ematiche prima e dopo la pandemia da SARS-CoV-2 in un ospedale di livello terziario del Nord-Est italiano.].

Lanzafame M, Tessari A, Agnoletto L, Coledan I, Adami I, Viviani F, Destro C. Lanzafame M, et al. Recenti Prog Med. 2022 Mar;113(3):213-215. doi: 10.1701/3761.37488. Recenti Prog Med. 2022. PMID: 35315453 Italian.

2

Performance of Alere Determine HIV-1/2 Ag/Ab Combo rapid test for acute HIV infection: a case report.

Lanzafame M, Zorzi A, Rigo F, Adami I, Del Bravo P, Tonolli E, Concia E, Azzini AM. Lanzafame M, et al. Infez Med. 2015 Mar;23(1):48-50. Infez Med. 2015. PMID: 25819051 Free article.

3

Short-cycle therapy in HIV-infected adults: rilpivirine combination 4 days on/3 days off therapy.

Luise D, Lattuada E, Rizzardo S, Nicolè S, Lambertenghi L, Coledan I, Gambino S, Gottardo R, Lanzafame M, Vento S. Luise D, et al. Among authors: lanzafame m. J Antimicrob Chemother. 2022 Feb 23;77(3):747-752. doi: 10.1093/jac/dkab442. J Antimicrob Chemother. 2022. PMID: 34849955

4

Clinical efficacy of different monoclonal antibody regimens among non-hospitalised patients with mild to moderate COVID-19 at high risk for disease progression: a prospective cohort study.

Savoldi A, Morra M, De Nardo P, Cattelan AM, Mirandola M, Manfrin V, Scotton P, Giordani MT, Brollo L, Panese S, Lanzafame M, Scroccaro G, Berkell M, Lippi G, Konnova A, Smet M, Malhotra-Kumar S, Kumar-Singh S, Tacconelli E; mAb Working Group. Savoldi A, et al. Among authors: lanzafame m. Eur J Clin Microbiol Infect Dis. 2022 Jul;41(7):1065-1076. doi: 10.1007/s10096-022-04464-x. Epub 2022 Jun 21. Eur J Clin Microbiol Infect Dis. 2022. PMID: 35727429 Free PMC article.

5

[No improvement of lipodystrophy syndrome in an HIV-infected patient].

Lanzafame M, Faggian F, Lattuada E, Antolini D, Concia E. Lanzafame M, et al. Recenti Prog Med. 2004 Jun;95(6):312-3. Recenti Prog Med. 2004. PMID: 15248414 Italian.

6

[CD4+ guided interruption HAART in HIV patients].

Antolini D, Lanzafame M, Lattuada E, Vento S, Concia E. Antolini D, et al. Among authors: lanzafame m. Recenti Prog Med. 2007 Oct;98(10):501-5. Recenti Prog Med. 2007. PMID: 17970175 Italian.

7

Is monoclonal antibody administration necessary in all vaccinated patients with breakthrough COVID-19 infections?

Lanzafame M, Gibbin E, Lattuada E, Vento S. Lanzafame M, et al. J Med Virol. 2022 Aug;94(8):3515-3516. doi: 10.1002/jmv.27802. Epub 2022 Apr 28. J Med Virol. 2022. PMID: 35451105 Free PMC article. No abstract available.

8

Benign acute viral myositis in African migrants: A clinical, serological, and pathological study.

Pancheri E, Lanzafame M, Zamò A, Angheben A, Sartoris S, Zorzi A, Boaretti M, Signoretto C, Guglielmi V, Ferrari S, Tonin P, Vattemi G. Pancheri E, et al. Among authors: lanzafame m. Muscle Nerve. 2019 Nov;60(5):586-590. doi: 10.1002/mus.26679. Epub 2019 Aug 30. Muscle Nerve. 2019. PMID: 31443116

9

Long-term efficacy of dual nucleoside reverse transcriptase inhibitor antiretroviral therapy in HIV-1 infection.

Vento S, Lanzafame M, Cainelli F, Faggian F, Concia E, Tositti G, Masiero G. Vento S, et al. Among authors: lanzafame m. AIDS. 2002 Jul 5;16(10):1432-3. doi: 10.1097/00002030-200207050-00020. AIDS. 2002. PMID: 12131225 No abstract available.

10

Pneumatocoele formation during Pneumocystis carinii pneumonia in a man with HIV-1 infection.

Lattuada E, Puppini G, Faggian F, Lanzafame M, Concia E. Lattuada E, et al. Among authors: lanzafame m. Lancet Infect Dis. 2004 Mar;4(3):170. doi: 10.1016/S1473-3099(04)00941-7. Lancet Infect Dis. 2004. PMID: 14998503 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

169 results

Search Page

Filters